The immunological consequences of photodynamic treatment of cancer, a literature review

Immunobiology

Volumn 207, Issue 2, 2003, Pages 105-113

  van Duijnhoven, Frederieke H ^a   Aalbers, Remco I J M ^a   Rovers, Jeroen P ^a   Terpstra, Onno T ^a   Kuppen, Peter J K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHITOSAN DERIVATIVE; CYTOKINE; EDRECOLOMAB; GLUCAN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE ACTIVATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOTOSENSITIZING AGENT; SCHIZOPHYLLAN; TALAPORFIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D BINDING PROTEIN;

ANTINEOPLASTIC ACTIVITY; BASEMENT MEMBRANE; CANCER CHEMOTHERAPY; CELL INTERACTION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MEDICAL LITERATURE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; STROMA CELL; TUMOR CELL; TUMOR IMMUNITY; VACCINATION;

EID: 0037240489     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00221     Document Type: Review

References (72)

1. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC and Hampson IN. 2001. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 61: 192-196.
2. Agarwal ML, Larkin HE, Zaidi SI, Mukhtar H and Oleinick NL. 1993. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res. 53: 5897-5902.
3. Ball DJ, Mayhew S, Wood SR, Griffiths J, Vernon DI and Brown SB. 1999. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge. Photochem. Photobiol. 69: 390-396.
4. Barrett KE, Yen A, Bigby TD, Montisano D and Gigli I. 1994. Inhibition of human peripheral blood lymphocyte function by protoporphyrin and longwave ultraviolet light. J. Immunol. 153: 3286-3294.
5. Blank M, Lavie G, Mandel M and Keisari Y. 2001. Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. Oncol. Res. 12: 409-418.
6. Casas A, Perotti C, Fukuda H and Batlle AMdC. 2002. Photodynamic therapy of activated and resting lymphocytes and its antioxidant adaptive response. Lasers Med. Sci. 17: 42-50.
7. Chen WR, Zhu WG, Dynlacht JR, Liu H and Nordquist RE. 1999. Long-term tumor resistance induced by laser photo-immunotherapy. Int. J. Cancer 81: 808-812.
8. Chen JY, Cheung NH, Fung MC, Wen JM, Leung WN and Mak NK. 2000. Subcellular localization of merocyanine 540 (MC540) and induction of apoptosis in murine myeloid leukemia cells. Photochem. Photobiol. 72: 114-120.
9. Chen JY, Mak NQ, Cheung NH, Leung RN and Peng Q. 2001. Endogenous production of protoporphyrin IX induced by 5-aminolevulinic acid in leukemia cells. Acta Pharmacol. Sin. 22: 163-168.
10. Coutier S, Bezdetnaya L, Marchal S, Melnikova V, Belitchenko I, Merlin JL and Guillemin F. 1999. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity. Br. J. Cancer 81: 37-42.
11. Del Governatore M, Hamblin MR, Shea CR, Rizvi I, Molpus KG, Tanabe KK and Hasan T. 2000. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res. 60: 4200-4205.
12. de Vree WJ, Fontijne-Dorsman AN, Koster JF and Sluiter W. 1996a. Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. Br. J. Cancer 73: 1335-1340.
13. de Vree WJ, Essers MC, de Bruijn HS, Star WM, Koster JF and Sluiter W. 1996b. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56: 2908-2911.
14. de Vree WJ, Essers MC, Koster JF and Sluiter W. 1997. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 57: 2555-2558.
15. Di Stefano A, Ettorre A, Sbrana S, Giovani C and Neri P. 2001. Purpurin-18 in combination with light leads to apoptosis or necrosis in HL60 leukemia cells. Photochem. Photobiol. 73: 290-296.
16. Elmets CA and Bowen KD. 1986. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res. 46: 1608-1611.
17. Fabris C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S and Reddi E. 2001. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res. 61: 7495-7500.
18. Fingar VH, Wieman TJ and Doak KW. 1990. Role of thromboxane and prostacyclin release on photodynamic therapy - induced tumor destruction. Cancer Res. 50: 2599-2603.
19. Fingar VH, Wieman TJ, Wiehle SA and Cerrito PB. 1992. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52: 4914-4921.
20. Fingar VH, Siegel KA, Wieman TJ and Doak KW. 1993. The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy. Photochem. Photobiol. 58: 393-399.
21. Gilissen MJ, Merbel-de Wit LE, Star WM, Koster JF and Sluiter W. 1993. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res. 53: 2548-2552.
22. Golab J, Wilczynski G, Zagozdzon R, Stoklosa T, Dabrowska A, Rybczynska J, Wasik M, Machaj E, Olda T, Kozar K, Kaminski R, Giermasz A, Czajka A, Lasek W, Feleszko W and Jakobisiak M. 2000. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br. J. Cancer 82: 1485-1491.
23. Gollnick SO, Liu X, Owczarczak B, Musser DA and Henderson BW. 1997. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57: 3904-3909.
24. Gollnick SO, Musser DA, Oseroff AR, Vaughan L, Owczarczak B and Henderson BW. 2001a. IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem. Photobiol. 74: 811-816.
25. Gollnick SO, Lee BY, Vaughan L, Owczarczak B and Henderson BW. 2001b. Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes. Photochem. Photobiol. 73: 170-177.
26. Gomer CJ, Ferrario A and Murphree AL. 1987. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br. J. Cancer 56: 27-32.
27. Gruner S, Volk HD, Noack F, Meffert H and von Baehr R. 1986. Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment. Tissue Antigens 27: 147-154.
28. Hagenaars M, Ensink NG, Basse PH, Hokland M, Nannmark U, Eggermont AM, van de Velde CJ, Fleuren GJ and Kuppen PJ. 2000. The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin. Exp. Metastasis 18: 189-196.
29. Henderson BW and Donovan JM. 1989. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res. 49: 6896-6900.
30. Hendrzak-Henion JA, Knisely TL, Cincotta L, Cincotta E and Cincotta AH. 1999. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem. Photobiol. 69: 575-581.
31. Herman S, Kalechman Y, Gafter U, Sredni B and Malik Z. 1996. Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. Immunopharmacology 31: 195-204.
32. Hryhorenko EA, Oseroff AR, Morgan J and Rittenhouse-Diakun K. 1998. Antigen specific and non-specific modulation of the immune response by aminolevulinic acid based photodynamic therapy. Immunopharmacology 40: 231-240.
33. Hunt DW, Jiang H, Granville DJ, Chan AH, Leong S and Levy JG. 1999. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 41: 31-44.
34. Jolles CJ, Ott MJ, Straight RC and Lynch DH. 1988. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am. J. Obstet. Gynecol. 158: 1446-1453.
35. Kessel D and Luo Y. 1998. Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. B 42: 89-95.
36. Kessel D, Luo Y, Deng Y and Chang CK. 1997. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65: 422-426.
37. King DE, Jiang H, Simkin GO, Obochi MO, Levy JG and Hunt DW. 1999. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand. J. Immunol. 49: 184-192.
38. Korbelik M and Cecic I. 1999. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. 137: 91-98.
39. Korbelik M, Krosl G, Krosl J and Dougherty GJ. 1996. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56: 5647-5652.
40. Korbelik M, Naraparaju VR and Yamamoto N. 1997. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br. J. Cancer 75: 202-207.
41. Korbelik M, Sun J and Posakony JJ. 2001. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem. Photobiol. 73: 403-409.
42. Krosl G and Korbelik M. 1994. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett. 84: 43-49.
43. Krosl G, Korbelik M and Dougherty GJ. 1995. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br. J. Cancer 71: 549-555.
44. Krosl G, Korbelik M, Krosl J and Dougherty GJ. 1996. Potentiation of photodynamic therapy-elicited anti-tumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 56: 3281-3286.
45. Kuppen PJ, van der Eb MM, Jonges LE, Hagenaars M, Hokland ME, Nannmark U, Goldfarb RH, Basse PH, Fleuren GJ, Hoeben RC and van de Velde CJ. 2001. Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem. Cell Biol. 115: 67-72.
46. Lavie G, Kaplinsky C, Toren A, Aizman I, Meruelo D, Mazur Y and Mandel M. 1999. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br. J. Cancer 79: 423-432.
47. Liang H, Shin DS, Lee YE, Nguyen DC, Trang TC, Pan AH, Huang SL, Chong DH and Berns MW. 1998. Subcellular phototoxicity of 5-aminolaevulinic acid (ALA). Lasers Surg. Med. 22: 14-24.
48. Luo Y and Kessel D. 1997. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem. Photobiol. 66: 479-483.
49. Nelson JS, Liaw LH, Orenstein A, Roberts WG and Berns MW. 1988. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl. Cancer Inst. 80: 1599-1605.
50. Obochi MO, Ratkay LG and Levy JG. 1997. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Transplantation 63: 810-817.
51. Oleinick NL and Evans HH. 1998. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150: S146-S156.
52. Pogue BW, Ortel B, Chen N, Redmond RW and Hasan T. 2001. A photobiological and photophysical-based study of phototoxicity of two chlorins. Cancer Res. 61: 717-724.
53. Qin B, Selman SH, Payne KM, Keck RW and Metzger DW. 1993. Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation. Transplantation 56: 1481-1486.
54. Reiter I, Schwamberger G and Krammer B. 1997. Effect of photodynamic pretreatment on the susceptibility of murine tumor cells to macrophage antitumor mechanisms. Photochem. Photobiol. 66: 384-388.
55. Reiter I, Schwamberger G and Krammer B. 1999. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro - indirect activation of macrophages by photodynamically killed tumor cells. J. Photochem. Photobiol. B 50: 99-107.
56. Roberts WG and Berns MW. 1989. In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-aspartyl chlorin e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II. Lasers Surg. Med. 9: 90-101.
57. Schreiber S, Gross S, Brandis A, Harmelin A, Rosenbach-Belkin V, Scherz A and Salomon Y. 2002. Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd- bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int. J. Cancer 99: 279-285.
58. Shulok JR, Wade MH and Lin CW. 1990. Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture. Photochem. Photobiol. 51: 451-457.
59. Simkin GO, Tao JS, Levy JG and Hunt DW. 2000. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J. Immunol. 164: 2457-2462.
60. Star WM, Marijnissen HP, Berg-Blok AE, Versteeg JA, Franken KA and Reinhold HS. 1986. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46: 2532-2540.
61. Steubing RW, Yeturu S, Tuccillo A, Sun CH and Berns MW. 1991. Activation of macrophages by Photofrin II during photodynamic therapy. J. Photochem. Photobiol. B 10: 133-145.
62. Thibaut S, Bourre L, Hernot D, Rousset N, Lajat Y and Patrice T. 2002. Effects of BAPTA-AM, Forskolin, DSF and Z.VAD.fmk on PDT-induced apoptosis and m-THPC phototoxicity on B16 cells. Apoptosis. 7: 99-106.
63. Usuda J, Okunaka T, Furukawa K, Tsuchida T, Kuroiwa Y, Ohe Y, Saijo N, Nishio K, Konaka C and Kato H. 2001. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int. J. Cancer 93: 475-480.
64. van Hillegersberg R, Hekking-Weijma JM, Wilson JH, Edixhoven-Bosdijk A and Kort WJ. 1995. Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model. Br. J. Cancer 71: 733-737.
65. Vantieghem A, Xu Y, Declercq W, Vandenabeele P, Denecker G, Vandenheede JR, Merlevede W, de Witte PA and Agostinis P. 2001. Different pathways mediate cytochrome c release after photodynamic therapy with hypericin. Photochem. Photobiol. 74: 133-142.
66. Wilson BC, Olivo M and Singh G. 1997. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy. Photochem. Photobiol. 65: 166-176.
67. Wyld L, Reed MW and Brown NJ. 2001. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br. J. Cancer 84: 1384-1386.
68. Wood SR, Holroyd JA and Brown SB. 1997. The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light. Photochem. Photobiol. 65: 397-402.
69. Yamamoto N, Homma S, Sery TW, Donoso LA and Hoober JK. 1991. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. Eur. J. Cancer 27: 467-471.
70. Yamamoto N, Sery TW, Hoober JK, Willett NP and Lindsay DD. 1994. Effectiveness of photofrin II in activation of macrophages and in vitro killing of retinoblastoma cells. Photochem. Photobiol. 60: 160-164.
71. Ziegler K and Unanue ER. 1981. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J. Immunol. 127: 1869-1875.
72. Ziolkowski P, Symonowicz K, Milach J, Zawirska B and Szkudlarek T. 1997. In vivo tumor necrosis factor-alpha induction following chlorin e6-photodynamic therapy in Buffalo rats. Neoplasma 44: 192-196.